Log in to search using one of your social media accounts:

 

Unrelenting NHS pressure affecting cancer care, say GPs and nurses
Half of GPs and primary care nurses not confident NHS workforce can provide adequate care Related items fromOnMedica Nasopharyngeal carcinoma and sinus cancer UK spends 20% less on cancer treatment than rest of EU Fifteen local NHS transformation projects to get cash boost The genetics of breast cancer Meeting cancer promises and more – a new model for NHS diagnostics? (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 8, 2017 Category: UK Health Source Type: news

Nutlin-3, a p53-Mdm2 antagonist for nasopharyngeal carcinoma treatment
(Bentham Science Publishers) Nasopharyngeal carcinoma (NPC) is a form of head and neck cancer that is highly prevalent among men in the populations of Southern China and Southeast Asia. This review will discuss the potential use of Nutlin-3 as a p53-activating drug and the future directions of its clinical research for NPC treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 23, 2017 Category: Cancer & Oncology Source Type: news

Liquid Biopsy Passes Test for Nasopharyngeal Cancer (CME/CE)
(MedPage Today) -- Impressive sensitivity and specificity in Chinese study (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 15, 2017 Category: Hematology Source Type: news

Early Detection of Nasopharyngeal Cancer With EBV DNA Early Detection of Nasopharyngeal Cancer With EBV DNA
Screening for Epstein-Barr virus DNA in plasma samples identified nasopharyngeal carcinoma significantly earlier compared with historical controls.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 10, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Analysis of EBV DNA in Plasma Samples IDs Nasopharyngeal CA
Screening detects nasopharyngeal carcinoma significantly earlier; linked to better outcomes (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 10, 2017 Category: Cancer & Oncology Tags: Infections, Oncology, ENT, Journal, Source Type: news

Breakthrough in tackling aggressive cancers
Finding could lead to new treatments Related items fromOnMedica Nasopharyngeal carcinoma and sinus cancer Underused cancer test could improve treatment of colon cancer Blood test may pick up bladder cancer ’s return before symptoms appear Tall men at higher risk of aggressive prostate cancer UK spends 20% less on cancer treatment than rest of EU (Source: OnMedica Latest News)
Source: OnMedica Latest News - August 3, 2017 Category: UK Health Source Type: news

Chemo Prior to CRT in Nasopharyngeal Carcinoma May Improve Outcomes
The addition of two cycles of neoadjuvant chemotherapy to concurrent chemoradiotherapy improved tumor control in patients with nasopharyngeal carcinoma. (Source: CancerNetwork)
Source: CancerNetwork - June 26, 2017 Category: Cancer & Oncology Authors: Dave Levitan Tags: Head & Neck Cancer News Source Type: news

Atara and Merck to investigate ATA129 + Keytruda for EBV-associated NPC
Biopharmaceutical firm Atara Biotherapeutics has entered a clinical trial collaboration agreement with Merck to evaluate the combination of its ATA129 with Keytruda (pembrolizumab) for the treatment of patients with nasopharyngeal carcinoma (NPC) ass … (Source: Drug Development Technology)
Source: Drug Development Technology - April 23, 2017 Category: Pharmaceuticals Source Type: news

A father ’s hope for his son’s life
Juan and Fredy in 2017. Juan was looking forward to having his son, Fredy, 14, finally come home to live with him. The teenager had been living under the care of his grandmother since he was a toddler. But on that long-awaited homecoming day, Juan was quickly jarred from feeling great joy to grave concern. “When I saw his face, one side looked very different from the other and his lip was swollen,” says Juan. “He admitted right away that his face had been hurting.” Juan remembered that the last time he’d seen his son — more than one year ago — Fredy’s face had looked slightly...
Source: Thrive, Children's Hospital Boston - April 12, 2017 Category: Pediatrics Authors: Kat J. McAlpine Tags: Diseases & Conditions Our Patients’ Stories Dr. Cameron Trenor Dr. Carolyn Rogers Dr. Darren Orbach Dr. Reza Rahbar Dr. Salim Afshar interventional radiology juvenile nasopharyngeal angiofibroma tumor Source Type: news

Gwyneth Paltrow And GOOP Give Dangerous Info On Iodine. Their Expert Gets His Info From A Ghost.
GOOP is at it again with the dangerous medical advice. This time they are leaving the vagina alone and focusing their dangerous energy vibrations on your thyroid. The article that caught my eye and my disgust is about iodine and the medical “expert” is a self-described medical medium (yes, you read that correctly) named Anthony William. What, pray tell, is a medial medium? Well, Mr. William claims he “was born with the unique ability to converse with a high-level spirit who provides him with extraordinarily accurate health information that’s often far ahead of its time.” That’s right, he...
Source: Healthy Living - The Huffington Post - February 14, 2017 Category: Consumer Health News Source Type: news

Patient Presents With Nasopharyngeal Lesion
A 19-year-old man is found to have a lesion in his nasopharynx, and a biopsy is performed. What is your diagnosis? (Source: CancerNetwork)
Source: CancerNetwork - January 13, 2017 Category: Cancer & Oncology Authors: Cesar A. Moran, MD Tags: Image IQ Source Type: news

Cancer Facts and Figures: Death Rate Down 25% Since 1991
By Stacy Simon The death rate from cancer in the US has declined steadily over the past 2 decades, according to annual statistics reporting from the American Cancer Society. The cancer death rate for men and women combined fell 25% from its peak in 1991 to 2014, the most recent year for which data are available. This decline translates to more than 2.1 million deaths averted during this time period. “Cancer Statistics, 2017,” published in the American Cancer Society’s journal CA: A Cancer Journal for Clinicians, estimates the numbers of new cancer cases and deaths expected in the US this year. The estimat...
Source: American Cancer Society :: News and Features - January 5, 2017 Category: Cancer & Oncology Tags: General Information Source Type: news

Locating the preferred imaging modality
Extensive radiologic tools exist to aid clinicians in the diagnostic process. The AHRQ National Guideline Clearinghouse allows clinicians to search the American College of Radiology ACR Appropriateness Criteria® to locate suggested criteria for ordering radiologic exams. Guidelines provide the suggested radiologic procedure that may be ordered for each presenting condition with a rating scale to denote the applicability for each exam. For each procedure the rating scale indicates the level of appropriateness of the exam. The guidelines also contain the relative radiation level for each type of exam. Additionally, a sum...
Source: Network News - January 4, 2017 Category: Databases & Libraries Authors: NN/LM South Central Region Tags: Patient Safety Source Type: news

Chronic Sinusitis Linked to Head and Neck Cancers in Elderly
Chronic sinusitis is associated with three rare types of head and neck cancer, including nasopharyngeal cancer, HPV-related oropharyngeal cancer, and nasal cavity and paranasal sinus cancers. (Source: CancerNetwork)
Source: CancerNetwork - September 10, 2016 Category: Cancer & Oncology Authors: Anna Azvolinsky Tags: Head & Neck Cancer News Source Type: news

MicroRNAs in Nasopharyngeal Carcinoma MicroRNAs in Nasopharyngeal Carcinoma
What is the role of miRNAs in the pathogenesis of nasopharyngeal carcinoma? Can they function as prognostic biomarkers?Chinese Clinical Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 5, 2016 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Genetic Susceptibility to the Endemic Form of NPC Genetic Susceptibility to the Endemic Form of NPC
Why is nasopharyngeal carcinoma so prevalent in certain geographic areas? Are genetics involved?Chinese Clinical Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 5, 2016 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

St. Jude Children's Research Hospital research being presented at ASCO Annual Meeting
(St. Jude Children's Research Hospital) St. Jude Children's Research Hospital research related to survivorship and the pediatric solid tumors neuroblastoma, adrenocortical carcinoma and nasopharyngeal carcinoma will be presented at the 2016 American Society of Clinical Oncology Annual Meeting. The five-day event begins June 3 in Chicago. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 3, 2016 Category: Cancer & Oncology Source Type: news

ACS Releases Long-term Care Guideline for Survivors of Head and Neck Cancer
By Stacy Simon The American Cancer Society has released a new Head and Neck Survivorship Care Guideline to help survivors of head and neck cancer and their primary care providers better manage their long-term care. The guideline addresses cancers of the oral cavity, tongue, lip, pharynx (throat), and larynx (voice box). Recommendations in the guideline may also apply to cancers of the salivary glands, nasal and paranasal sinuses, and nasopharynx. But it does not address cancers of the brain, thyroid, or esophagus because they are very different in terms of symptoms and treatment. RESOURCES: Head and Neck Cancer Survivor...
Source: American Cancer Society :: News and Features - March 23, 2016 Category: Cancer & Oncology Tags: Oral Cavity and Oropharyngeal Cancer Laryngeal and Hypopharyngeal Cancer Salivary Gland Cancer Nasal Cavity and Paranasal Sinus Cancer Nasopharyngeal Cancer Source Type: news

Cuba Has Made At Least 3 Major Medical Innovations That We Need
By most measures, the United States' business-friendly environment has proven to be fertile for medical innovation. Compared to other countries, America has filed the most patents in the life sciences, is conducting most of the world's clinical trials and has published the most biomedical research. That's what makes the medical prominence of Cuba all the more surprising to those who view a free market as an essential driver of scientific discovery. Cuba is very poor, and yet the country has some of the healthiest, most long-lived residents in the world -- as well as a medical invention or two that could run circl...
Source: Science - The Huffington Post - March 15, 2016 Category: Science Source Type: news

New Findings Show Anti-Tumor Activity of KEYTRUDA® (pembrolizumab) in Patients with Advanced Nasopharyngeal Carcinoma
Dateline City: KENILWORTH, N.J. KEYTRUDA Monotherapy Achieved Overall Response Rate of 22.2 Percent in Previously-Treated Patients Results from KEYNOTE-028 Presented at 2015 European Cancer Congress KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the first-time presentation of findings investigating the use of KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 therapy, as a monotherapy in patients with advanced unresectable nasopharyngeal carcinom...
Source: Merck.com - Corporate News - September 26, 2015 Category: Pharmaceuticals Tags: Oncology Newsroom Prescription Medicine News Corporate News Latest News Source Type: news

New Findings Show Anti-Tumor Activity of KEYTRUDA ® (pembrolizumab) in Patients with Advanced Nasopharyngeal Carcinoma
Dateline City: KENILWORTH, N.J. KEYTRUDA Monotherapy Achieved Overall Response Rate of 22.2 Percent in Previously-Treated Patients Results from KEYNOTE-028 Presented at 2015 European Cancer Congress KENILWORTH, N.J.--( BUSINESS WIRE )--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the first-time presentation of findings investigating the use of KEYTRUDA ® (pembrolizumab), the company ’s anti-PD-1 therapy, as a monotherapy in patients with advanced unresectable nasopharyngeal carcinoma (NPC) – a type of head and neck cancer ...
Source: Merck.com - Product News - September 26, 2015 Category: Drugs & Pharmacology Tags: Oncology Newsroom Prescription Medicine News Corporate News Latest News Source Type: news

Data in Nine Difficult-to-Treat Cancers from Merck’s KEYTRUDA® (pembrolizumab) Development Program to be Presented at European Cancer Congress 2015, Including Data in Four New Cancer Types: ...
Dateline City: KENILWORTH, N.J. ...Nasopharyngeal Carcinoma, Anal Cancer, Merkel Cell Carcinoma and Biliary Tract Cancer Data to Include First-Time Findings on the Potential Importance of PD-L2 Expression in Predicting Patient Responsiveness to Anti-PD-1 Therapy KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that new data investigating the anti-tumor activity of KEYTRUDA® (pembrolizumab) across a broad range of advanced cancers will be presented at t...
Source: Merck.com - Product News - September 21, 2015 Category: Drugs & Pharmacology Tags: Oncology Newsroom Prescription Medicine News Research and Development News Corporate News Latest News Source Type: news

Data in Nine Difficult-to-Treat Cancers from Merck ’s KEYTRUDA® (pembrolizumab) Development Program to be Presented at European Cancer Congress 2015, Including Data in Four New Cancer Types: ...
Dateline City: KENILWORTH, N.J. ...Nasopharyngeal Carcinoma, Anal Cancer, Merkel Cell Carcinoma and Biliary Tract Cancer Data to Include First-Time Findings on the Potential Importance of PD-L2 Expression in Predicting Patient Responsiveness to Anti-PD-1 Therapy KENILWORTH, N.J.--( BUSINESS WIRE )--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that new data investigating the anti-tumor activity of KEYTRUDA ® (pembrolizumab) across a broad range of advanced cancers will be presented at this year ’s European Cancer Congress (ECC) ...
Source: Merck.com - Product News - September 21, 2015 Category: Drugs & Pharmacology Tags: Oncology Newsroom Prescription Medicine News Research and Development News Corporate News Latest News Source Type: news

Heartbreak as young father told the lumps on his neck were due to an infection discovers he has terminal cancer after GOOGLING his symptoms
Tom Cooper, 28, from Burnley, has been diagnosed with a terminal form of Nasopharyngeal Carcinoma. He is cared for by his wife, Tammy, 26, and daughters: Tienna, seven, and Ziani, four. (Source: the Mail online | Health)
Source: the Mail online | Health - May 13, 2015 Category: Consumer Health News Source Type: news

Engineered cells could help tackle the third most common cancer in Chinese males
(University of Birmingham) Researchers at the University of Birmingham believe that a new method of genetically engineering immune cells could lead to improved treatment of Nasopharyngeal carcinoma patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 10, 2015 Category: Cancer & Oncology Source Type: news

Potential avenues for treatment of deadly nasopharyngeal cancer discovered
A distinct mutational signature and nine significantly mutated genes associated with nasopharyngeal cancer have been found by an international team of researchers, paving the way to developing novel therapies for this deadly disease. The group has conducted the first successful comprehensive genomic study of nasopharyngeal carcinoma, which has a particularly high prevalence in Southern China and Southeast Asia, including Singapore. The findings provide an enhanced road map for the study of the molecular basis of this form of cancer. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 23, 2014 Category: Science Source Type: news

New study offers potential avenues for treatment of deadly nasopharyngeal cancer
(National University of Singapore) A team of scientists from the Cancer Science Institute of Singapore at the National University of Singapore, National University Cancer Institute Singapore and National University Hospital Singapore, discovered a distinct mutational signature and nine significantly mutated genes associated with nasopharyngeal cancer, paving the way to developing novel therapies for this deadly disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 23, 2014 Category: Cancer & Oncology Source Type: news

Mother-of-two prescribed ear drops for hearing loss discovers she has a huge cancerous tumour growing behind her face
Claire Hessan, 39, from Cornwall, was diagnosed with nasopharyngeal cancer a year after first visiting the doctor complaining of hearing loss, a strange itch in her ear and lumps in her neck. (Source: the Mail online | Health)
Source: the Mail online | Health - June 3, 2014 Category: Consumer Health News Source Type: news

Pamela Youde Nethersole Eastern Hospital First in Asia to Treat Cancer using TrueBeam 2.0 System for Image-Guided Radiotherapy and Radiosurgery
New technology now being used to treat nasopharyngeal and other cancers; stereotactic radiosurgery program for select cancers coming in June HONG KONG, May 19, 2014 -- (Healthcare Sales & Marketing Network) -- Pamela Youde Nethersole Eastern Hospital (... Devices, OncologyVarian Medical Systems, radiosurgery, radiotherapy, TrueBeam (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 19, 2014 Category: Pharmaceuticals Source Type: news

Nasopharyngeal Cancer
Title: Nasopharyngeal CancerCategory: Diseases and ConditionsCreated: 4/23/2008 12:00:00 AMLast Editorial Review: 4/2/2014 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 2, 2014 Category: Cancer & Oncology Source Type: news

Smoking reduces nasopharyngeal cancer survival
Both current and former smoking have a significant impact on the prognosis of patients with nasopharyngeal carcinoma, Chinese researchers caution. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - November 27, 2013 Category: Cancer & Oncology Source Type: news

Predicting nasopharyngeal carcinoma patient response to radiation therapy
(Journal of Clinical Investigation) In this issue of the Journal of Clinical Investigation, Yu-Sun Chang and colleagues at Chang Gung University sought to find a way to predict which individual cases of NPC would be sensitive to radiation therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 25, 2013 Category: Cancer & Oncology Source Type: news

JCI early table of contents for Nov. 25, 2013
(Journal of Clinical Investigation) This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, Nov. 25, 2013, in the JCI: Predicting nasopharyngeal carcinoma patient response to radiation therapy; Circadian clock proteins maintain neuronal cell function; Identifying targets of autoantibodies; Balancing T cell populations; Identification of a genetic mutation associated with steroid-resistant nephritic syndrome; Insights into type 2B von Willebrand disease, and more. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 25, 2013 Category: Cancer & Oncology Source Type: news

Cetuximab and Chemoradiation in Nasopharyngeal CarcinomaCetuximab and Chemoradiation in Nasopharyngeal Carcinoma
Learn about treatment compliance, acute toxicities and the short-term curative effects of combining cetuximab with chemoradiation following induction chemotherapy of locoregionally advanced nasopharyngeal carcinoma. Future Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 28, 2013 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Moving closer to Epstein-Barr virus vaccine to prevent mono, some cancers
Development of a vaccine against Epstein-Barr virus (EBV) has taken a step forward with the Canadian discovery of how EBV infection evades detection by the immune system. EBV causes infectious mononucleosis and cancers such as Hodgkin's lymphoma and nasopharyngeal carcinoma, which is the most common cancer in China, as well as opportunistic cancers in people with weakened immune systems. A member of the herpes virus family that remains in the body for life, the virus infects epithelial cells in the throat and immune cells called B cells... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 15, 2013 Category: Consumer Health News Tags: Lymphoma / Leukemia / Myeloma Source Type: news

In Intermediate-Risk Nasopharyngeal Cancers, PET/CT Appropriate for Detecting Distant Metastases
Researchers in China have found that the use of [18F] fluorodeoxyglucose PET/CT detected a greater number of distant metastases than conventional work-up imaging in patients with nasopharyngeal carcinoma. (Source: Cancer Network)
Source: Cancer Network - August 23, 2013 Category: Cancer & Oncology Source Type: news

[Research Article] CCAAT Enhancer Binding Protein {delta} in Macrophages Contributes to Immunosuppression and Inhibits Phagocytosis in Nasopharyngeal Carcinoma
The transcription factor C/EBP{delta} makes tumor-associated macrophages produce signals that aid the tumor. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - July 19, 2013 Category: Science Authors: Yu-Wei Hsiao, Chien-Feng Li, Jhih-Ying Chi, Joseph T. Tseng, Yao Chang, Li-Jin Hsu, Chien-Hsun Lee, Tsung-Hao Chang, Shao-Ming Wang, Dennis Ding Hwa Wang, Hung-Chi Cheng, Ju-Ming Wang Source Type: news

Adding Oxaliplatin to Radiotherapy in Nasopharyngeal CancerAdding Oxaliplatin to Radiotherapy in Nasopharyngeal Cancer
Adding oxaliplatin to radiotherapy (RT) for locoregionally advanced nasopharyngeal carcinoma appears to have lasting survival benefits, according to Chinese researchers. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 27, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Chemo and RT Combination Helpful in Nasopharyngeal CancerChemo and RT Combination Helpful in Nasopharyngeal Cancer
Concurrent chemoradiotherapy plus adjuvant chemotherapy continues to offer significant survival benefits over radiotherapy (RT) alone in patients with advanced nasopharyngeal carcinoma. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 22, 2013 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Nasopharyngeal Carcinoma
Keys for Translational Medicine and Biologyseries:Advances in Experimental Medicine and BiologyThis volume intends to contribute to “translational medicine and biology”. By this, we mean a bi-directional process whose aim is to develop knowledge from basic science towards diagnostic and therapeutic applications and reciprocally to raise new questions for basic scientists. One general requirement for translational research is to establish a multidisciplinary knowledge base shared by the ... (Source: Springer Biomedical Sciences titles)
Source: Springer Biomedical Sciences titles - April 5, 2013 Category: Biomedical Science Tags: Biomedicine (general) Source Type: news